StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Moderna (MRNA) PT Lowered to $25 at Wolfe Research
February 14, 2025 2:07 PM
Wolfe Research analyst Alexandria Hammond lowered the price target on Moderna (NASDAQ: MRNA) to ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
Barclays Downgrades Moderna (MRNA) to Equalweight
February 18, 2025 5:13 AM
Moderna (MRNA) Misses Q4 EPS by 18c; offers guidance
February 14, 2025 7:10 AM
Moderna norovirus vaccine trial on hold by US FDA over neurological side effect
February 14, 2025 6:34 AM
Form 8-K Moderna, Inc. For: Feb 14
February 14, 2025 6:31 AM
Moderna Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Updates
February 14, 2025 6:29 AM
Moderna faces revenue pressures as analysts cut estimates ahead of earnings
February 14, 2025 2:00 AM
RFK, Jr. said confirmed
February 13, 2025 11:20 AM
Moderna (MRNA) call put ratio 1.6 calls to 1 put into quarter results
February 13, 2025 10:30 AM
Moderna (MRNA) call put ratio 1.4 calls to 1 put into quarter results
February 13, 2025 5:39 AM
Form SCHEDULE 13G/A Moderna, Inc. Filed by: BAILLIE GIFFORD & CO
February 12, 2025 9:08 AM
